Projected Annual Impact
Lockton – Callaway Brands
12/1/2024 to 11/30/2025
$541K
Savings Net of Fees
12.3% ↓
8:1 ROI
PROJECTED FEES: $75,784
Specialty RxGuidance Savings Analysis
Lockton – Callaway Brands
Data Summary 2/1/2025 to 11/30/2025
| Total Scripts: | 18,501 |
| Total Plan Paid: | $4,164,229 |
| Specialty Scripts: | 637 |
| Specialty Plan Paid: | $1,887,581 |
| Specialty Members: | 174 |
* Specialty accounts for 3.4% of total scripts
* Specialty accounts for 45.3% of total plan spend
Projected Specialty Savings $182,007
Remaining Plan Paid
Projected Savings
Specialty RxGuidance Benchmark Analysis
Lockton – Callaway Brands
12/1/2024 to 11/30/2025
Data Summary
| Total Rxs: | 22,622 |
| Total Plan Paid: | $5,008,620 |
| Specialty Members: | 2,589 |
Actual Plan Experience
| Specialty Rxs: | 415 |
| Specialty Plan Paid: | $2,359,401 |
| Avg Plan Paid / Rx: | $5,685 |
RxResults’ Experience
| Specialty Rxs: | 360 |
| Specialty Plan Paid: | $2,046,600 |
| Avg Plan Paid / Rx: | $5,685 |
*RxResults’ experience normalized to 22,622 Rxs under RxResults management.
• Specialty drugs account for 1.8% of total Rxs
• Specialty drugs account for 47.1% of total plan paid
RxResults Benchmark vs. Plan’s Specialty Drug Spend $312,801
RxResults Benchmark
Savings Opportunity
RxGuidance Savings Analysis
Lockton – Callaway Brands
Date Range: 12/1/2024 to 11/30/2025
$304,703 in savings by impacting 6.8% of all Rxs
Data Summary – All Rxs
| Rxs: | 22,622 |
| Brand: | 3,323 |
| Generic: | 19,299 |
| Generic utilization rate: | 85.3% |
| Total drug cost: | $5,008,620 |
Data Summary – Targeted Rxs
| Rxs | % of all Rxs | Projected Savings | Savings/Rx | |
|---|---|---|---|---|
| Brand | 286 | 1.3% | $212,706 | $744 |
| Generic | 1,247 | 5.5% | $91,997 | $74 |
| Totals | 1,533 | 6.8% | $304,703 | $199 |
Number of unique impacted members: 547
Avg plan savings per impacted member: $557
Projected Plan Savings $304,703
Projected Plan Spend
Savings
Targeted Rxs — Current vs. Projected Paid / Rx
Current Paid / Rx
Projected Paid / Rx
Callaway Brands
Top 10 Products by Savings Amount — 12/1/2024 to 11/30/2025
| Class | Mbrs | Rxs | Plan Paid | Avg Plan Paid / Rx | Savings | Savings / Rx | B/G |
|---|---|---|---|---|---|---|---|
| Anticonvulsants – Misc. | 3 | 11 | $37,155.23 | $3,377.75 | $37,120.43 | $3,374.58 | B |
| Amphetamines | 33 | 134 | $27,436.04 | $204.75 | $26,976.54 | $201.32 | G |
| Anticonvulsants – Misc. | 1 | 4 | $20,606.91 | $5,151.73 | $20,574.51 | $5,143.63 | B |
| Serotonin Modulators | 5 | 24 | $18,691.34 | $778.81 | $18,622.94 | $775.96 | B |
| Combination Contraceptives – Oral | 13 | 38 | $18,867.62 | $496.52 | $18,459.94 | $485.79 | B |
| Antihyperlipidemics – Combinations | 4 | 19 | $14,024.80 | $738.15 | $9,817.36 | $516.70 | B |
| Stimulants – Misc. | 2 | 19 | $7,851.28 | $413.23 | $7,796.28 | $410.33 | B |
| Ophthalmic Immunomodulators | 2 | 17 | $12,634.29 | $743.19 | $7,580.58 | $445.92 | B |
| Amphetamines | 4 | 12 | $7,266.78 | $605.57 | $7,208.28 | $600.69 | B |
| Calcitonin Gene-Related Peptide (CGRP) Receptor Antag | 5 | 13 | $23,422.52 | $1,801.73 | $7,026.76 | $540.52 | B |